Tuesday, June 17, 2025 | 04:53 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Alkem Laboratories launches Ibuprofen and Famotidine Tablets in US market

Image

Capital Market
Alkem Laboratories (Alkem) today announced the launch of Ibuprofen and Famotidine Tablets (800 mg/26.6 mg) in the United States, following an approval from the United States Food and Drug Administration (US FDA).

Ibuprofen and Famotidine Tablets is AB-rated generic therapeutic equivalent version of Horizon Medicines LLC's Duexis Tablets, 800 mg/26.6 mg. This is the first generic approval of Duexis Tablets, 800 mg/26.6 mg by the US FDA. The launch is a subject of ongoing litigation.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 04 2021 | 9:19 AM IST

Explore News